|
|
|
0 members (),
2,316
guests, and
27
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
1
|
2
|
3
|
4
|
5
|
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
|
27
|
28
|
29
|
30
|
|
|
|
|
There are no members with birthdays on this day. |
Volcano earthquake report for Monday, 28 September 2026
• M 4.9 - 124 km SE of Pondaguitan, Philippines
• M 4.9 - 124 km SE of Pondaguitan, Philippines
• M 4.2 - 7 km SE of Denali National Park, Alaska
• M 5.4 - north of Svalbard
• M 2.4 - 70 km SSW of Nikolski, Alaska
|
#54778
Tue 05 Apr 2011 06:17:PM
|
Joined: Feb 2001
Posts: 678,977
Launch Director
|
|
Launch Director
Joined: Feb 2001
Posts: 678,977 |
Researchers may have found a way to turn an adaptive cellular response into a liability for cancer cells, by treating a group of patients with several different types of advanced cancers with temsirolimus, a molecularly targeted cancer drug that blocks nutrient uptake, plus hydroxychloroquine, an anti-malarial drug that inhibits autophagy. This regimen halted tumor growth in two-thirds of the patients.  Source: Modern targeted drug plus old malaria pill serve a one-two punch in advanced cancer patients
David Cottle
UBB Owner & Administrator
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
|
Forums60
Topics844,707
Posts879,502
Members2,960
| |
Most Online102,106
Jul 10th, 2026
|
|
|
|
|
|
